Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tefluthrin SCHEMBL20823 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL16536934 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL2740810 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL14427331 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL4622567 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL4622566 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL1920781 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL8769136 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL1898396 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM | |
| Tefluthrin SCHEMBL21112033 | 1.00 | TDP1 (1.00) | TDP1MEN1KMT2ALMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008085363-A1 | COMBINATION LIGHT DEVICE WITH INSECT CONTROL INGREDIENT EMISSION | S. C. JOHNSON & SON, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20080113940-A1 | Insecticidal Compositions | ERDELEN CHRISTOPH | 2008-05-15 | — | — | US | claimed |
| EP-1649750-A2 | Synergistic insecticidal mixtures based on chloronicotinyl insecticides | Bayer CropScience AG (DE) | 2006-04-26 | — | — | EP | claimed |
| US-20020193352-A1 | Insecticides | ERDELEN CHRISTOPH (DE) | 2002-12-19 | — | — | US | claimed |
| US-20010025050-A1 | Insecticidal compositions | ERDELEN CHRISTOPH (DE) | 2001-09-27 | — | — | US | claimed |
| US-6218407-B1 | Insecticides | BAYER AKTIENGESELLSCHAFT (DE) | 2001-04-17 | — | — | US | claimed |
| EP-0828421-A1 | INSECTICIDES | BAYER AG (DE) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037105-A1 | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-11-28 | — | — | WO | claimed |
| US-6444690-B1 | — | — | None | — | — | US | disclosed |
| WO-2015028034-A1 | COMBINATION OF 2,3,5,6-TETRAFLUORO-4-METHYLBENZYL (Z)-(1 R)-CIS-3-(2-CHLORO-3,3,3-TRIFLUORO-1 -PROPENYL)-2,2-DIMETHYLCYCLOPROPANECARBOXYLATE WITH AT LEAST ONE INSECTICIDE, ACARICIDE, NEMATICIDE AND/OR FUNGICIDE. | CHEMINOVA A/S (DK) | 2015-03-05 | — | — | WO | disclosed |
| WO-2015028034-A1 | COMBINATION OF 2,3,5,6-TETRAFLUORO-4-METHYLBENZYL (Z)-(1 R)-CIS-3-(2-CHLORO-3,3,3-TRIFLUORO-1 -PROPENYL)-2,2-DIMETHYLCYCLOPROPANECARBOXYLATE WITH AT LEAST ONE INSECTICIDE, ACARICIDE, NEMATICIDE AND/OR FUNGICIDE. | CHEMINOVA A/S (DK) | 2015-03-05 | — | — | WO | disclosed |
| US-20110144058-A1 | INSECTICIDAL COMPOSITIONS | BAYER CROPSCIENCE AG (DE) | 2011-06-16 | — | — | US | disclosed |
| US-7445791-B2 | Synergistic insecticidal composition containing Chloronicotynyle and Organosphosphorus compounds | UNITED PHOSPHORUS, LTD. (IN) | 2008-11-04 | — | — | US | disclosed |
| US-20080113940-A1 | Insecticidal Compositions | ERDELEN CHRISTOPH | 2008-05-15 | — | — | US | disclosed |
| US-20020193352-A1 | Insecticides | ERDELEN CHRISTOPH (DE) | 2002-12-19 | — | — | US | disclosed |
| US-6444690-B2 | INSECTICIDAL MIXTURES OF CHLORONICOTINYL INSECTICIDES WITH ONE OR MORE SYNERGISTS FROM THE GROUP AZINPHOS-METHYL, CURACRON, MESUROL, CHLORFENAPYR, TAMARON, ABAMECTIN, TRIAZURON, ENDOSULFAN, HEXYTHIAZOX, METHIOCARB AND OTHERS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-09-03 | — | — | US | disclosed |
| US-20010025050-A1 | Insecticidal compositions | ERDELEN CHRISTOPH (DE) | 2001-09-27 | — | — | US | disclosed |
| US-6225495-B1 | PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-05-01 | — | — | US | disclosed |
| US-6060489-A | SYNERGISTIC MIXTURE COMPRISING IMIDACLOPRID AND MESUROL; ARACHNIDS, NEMATODES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-05-09 | — | — | US | disclosed |
| US-5994331-A | SYNERGISTIC MIXTURE | BAYER ATIENGESELLSCHAFT (DE) | 1999-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113940-A1 | Insecticidal Compositions | CBR3, CBR1, CNPY3 | TDP1 4395/4885MEN1 2348/4885KMT2A 2488/4885 |
| US-20020193352-A1 | Insecticides | CBR1, CBR3, CLIC1 | TDP1 2886/4885MEN1 2524/4885KMT2A 2043/4885 |
| US-20110144058-A1 | INSECTICIDAL COMPOSITIONS | CBR3, CBR1, CNPY3 | TDP1 4414/4885MEN1 2210/4885KMT2A 2602/4885 |
| US-20010025050-A1 | Insecticidal compositions | CBR3, CBR1, CYCS | TDP1 3812/4885MEN1 3242/4885KMT2A 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.